Page 1428 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 5

149. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute 161. Morelli A, Rizzi C, Bellomo R, et al. Prophylactic fenoldopam
tubular necrosis. Auriculin Anaritide Acute Renal Failure Study for renal protection in sepsis: a randomized, double-blind,
Group. N Engl J Med. 1997;336:828. placebo-controlled pilot trial. Crit Care Med. 2005;33(11):
150. Lewis J, et al. Atrial natriuretic factor in oliguric acute renal 2451-2456.
failure. Anaritide Acute Renal Failure Study Group. Am J Kidney 162. Ding H, Kopple JD, Cohen A, et al. Recombinant human
Dis. 2000;36:767. insulin-like growth factor-I accelerates recovery and reduces
151. Sward K, Valsson F, Odencrants P, et al. Recombinant human catabolism in rats with ischemic acute renal failure. J Clin Invest.
atrial natriuretic peptide in ischemic acute renal failure: a ran- 1993;91:2281-2287.
domized, placebo-controlled trial. Crit Care Med. 2004;32:1310. 163. Franklin SC, Moulton M, Sicard GA, et al. Insulin-like growth
152. Nigwekar S, Hix J. The role of natriuretic peptide administra- factor I preserves renal function postoperatively. Am J Physiol.
tion in cardiovascular surgery–associated renal dysfunction: a 1997;272:F257-F259.
systematic review and meta-analysis of randomized controlled 164. Hladunewich MA, Corrigan G, Derby GC, et al. A random-
trials. J Cardiothorac Vasc Anesth. 2009;23(2):151-160. ized, placebocontrolled trial of IGF-1 for delayed graft func-
153. Nigwekar S, Navaneethan S, Parikh C, et al. Atrial Natriuretic tion: a human model to study postischemic ARF. Kidney Int.
Peptide for management of acute kidney injury: a systematic 2003;64:593-602.
review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:261-272. 165. Hirschberg R, Kopple J, Lipsett P, et al. Multicenter clinical trial
154. Murray PT. Use of dopaminergic agents for renoprotection in of recombinant human insulin-like growth factor I in patients
the ICU. Yearbook of Intensive Care and Emergency Medicine, with acute renal failure. Kidney Int. 1999;55:2423-2432.
Springer-Verlag, 2003:637. 166. Fiaccadori E, Regolisti G, Cabassi A. Specific nutritional prob-
155. Denton MD, Chertow GM, Brady HR. “Renal-dose” dopamine lems in acute kidney injury, treated with non-dialysis and dia-
for the treatment of acute renal failure: scientific rationale, lytic modalities. Nephrol Dial Transplant Plus. 2010;3:1-7.
experimental studies and clinical trials. Kidney Int. 1996;49:4. 167. Fiaccadori E, Lombardi M, Leonardi S, et al. Prevalence and
156. Kellum JA, Decker JM. Use of dopamine in acute renal failure: clinical outcome associated with preexisting malnutrition in
a meta-analysis. Crit Care Med. 2001;29:1526. acute renal failure: a prospective cohort study. J Am Soc Nephrol.
1999;10:581-593.
157. Marik PE. Low-dose dopamine: a systematic review. Intensive
Care Med. 2002;28:877. 168. Fiaccadori E, Maggiore U, Rotelli C, et al. Effects of different
energy intakes on nitrogen balance in patients with acute renal
158. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopa- failure: a pilot study. Nephrol Dial Transplant. 2005;20:1976-1980.
mine in patients with early renal dysfunction: a placebo-
controlled randomised trial. Australian and New Zealand 169. Montgomerie JZ, Kalmanson GM, Guze LB. Renal failure and
Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. infection. Medicine. 1968;47:1.
2000;(9248):2139-2143. 170. Remuzzi G. Bleeding in renal failure. Lancet. 1988;1:1205.
159. Friedrich J, Adhikari N, Herridge M, et al. Meta-analysis: low- 171. Bridges KR. Hemorrhagic complications associated with renal
dose dopamine increases urine output but does not prevent failure. J Crit Illness. 1989;4:17.
renal dysfunction or death. Ann Intern Med. 2005;142:510-524. 172. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-d-
160. Landoni G, Biondi-Zoccai G, Marino G, et al. Fenoldopam arginine vasopressin shortens the bleeding time in uremia.
reduces the need for renal replacement therapy and in-hospital N Engl J Med. 1983;308:8.
death in cardiovascular surgery: a meta-analysis. Journal of 173. Janson PA, Kosfeld R, Marcum S. Treatment of uremic bleeding
Cardiothoracic and Vascular Anesthesia. 2008;22(1):27-33. with conjugated oestrogen. Lancet. 1984;2:887.

Section08-O-Ref.indd 5 12/10/2014 6:08:08 PM